Equity Overview
Price & Market Data
Price: $1.27
Daily Change: -$0.01 / 0.79%
Daily Range: $0 - $0
Market Cap: $76,571,728
Daily Volume: 0
Company Details
Employees: 149
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.